GlaxoSmithKline posts Q2FY22 consolidated PAT at Rs. 204.24 Cr

GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021

Dr Reddys Laboratories posts Q2FY22 PAT at Rs 992 Cr

Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021

Holborn Wells and SpeedBio India forms JV to manufacture in vitro diagnostics

Both parties are expected to invest a total of US $ 1 million to establish the brand

NH TherAguix releases new batch for AGuIX

The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company

Merck expands capacity for Antibody Drug Conjugate (ADC), therapies

Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges

3M Health Care and Thermo Fisher to increase efficiency in therapeutic manufacturing

Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers

Finvasia acquires Gini Health as it moves into healthcare tech

Gini Health works in the domain of personalised healthcare

Transforming Healthcare Through AI

Thermo Fisher Scientific unveils Q Digital PCR system

It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development

10x Genomics opens Singapore manufacturing hub

Strengthens supply chain continuity with first manufacturing facility outside of the U.S.